Protecting infants from respiratory syncytial virus (RSV) in Ireland: Impact of a national nirsevimab immunisation programme, 2024/2025
- DOI
- 10.1016/j.vaccine.2026.128344
- Published
- 2026-03
- Container
- Vaccine
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.vaccine.2026.128344,
title = {Protecting infants from respiratory syncytial virus (RSV) in Ireland: Impact of a national nirsevimab immunisation programme, 2024/2025},
author = {Laura Paris and Lisa Domegan and Maureen O'Leary and Michael Hanrahan and Adele McKenna and Eva Kelly and Carina Brehony and Katie O'Brien and Margaret Fitzgerald and Eve Robinson and Augustine Pereira and Éamonn O'Moore},
year = {2026},
journal = {Vaccine},
doi = {10.1016/j.vaccine.2026.128344},
url = {https://doi.org/10.1016/j.vaccine.2026.128344}
}RIS
TY - JOUR TI - Protecting infants from respiratory syncytial virus (RSV) in Ireland: Impact of a national nirsevimab immunisation programme, 2024/2025 AU - Laura Paris AU - Lisa Domegan AU - Maureen O'Leary AU - Michael Hanrahan AU - Adele McKenna AU - Eva Kelly AU - Carina Brehony AU - Katie O'Brien AU - Margaret Fitzgerald AU - Eve Robinson AU - Augustine Pereira AU - Éamonn O'Moore PY - 2026 JO - Vaccine DO - 10.1016/j.vaccine.2026.128344 UR - https://doi.org/10.1016/j.vaccine.2026.128344 ER -
APA
Paris, L., Domegan, L., O'Leary, M., Hanrahan, M., McKenna, A., Kelly, E., Brehony, C., O'Brien, K., Fitzgerald, M., Robinson, E., Pereira, A., & O'Moore, É. (2026). Protecting infants from respiratory syncytial virus (RSV) in Ireland: Impact of a national nirsevimab immunisation programme, 2024/2025. Vaccine. https://doi.org/10.1016/j.vaccine.2026.128344
Source records
- crossref · retrieved 2026-09-26T03:11:31.887Z